| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 148.47B | 144.07B | 144.18B | 124.96B | 110.78B | 99.97B |
| Gross Profit | 36.92B | 35.14B | 33.03B | 27.41B | 24.56B | 19.95B |
| EBITDA | 18.45B | 20.25B | 26.64B | 13.78B | 12.19B | 9.87B |
| Net Income | 8.62B | 9.78B | 15.28B | 8.31B | 5.31B | 2.11B |
Balance Sheet | ||||||
| Total Assets | 213.78B | 195.21B | 155.14B | 143.90B | 119.71B | 110.20B |
| Cash, Cash Equivalents and Short-Term Investments | 26.15B | 26.74B | 21.38B | 18.32B | 16.89B | 15.72B |
| Total Debt | 75.23B | 61.92B | 28.08B | 34.30B | 22.85B | 13.68B |
| Total Liabilities | 120.68B | 101.38B | 68.17B | 72.47B | 56.47B | 39.87B |
| Stockholders Equity | 87.76B | 89.00B | 83.42B | 68.11B | 60.17B | 60.68B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 7.26B | 6.05B | 3.65B | 5.96B | 5.01B |
| Operating Cash Flow | 0.00 | 13.10B | 11.75B | 10.28B | 9.49B | 9.33B |
| Investing Cash Flow | 0.00 | -29.83B | 2.58B | -15.95B | -5.17B | -4.01B |
| Financing Cash Flow | 0.00 | 22.00B | -11.49B | 6.84B | -3.35B | -2.41B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥98.33B | 0.94 | ― | 4.28% | 12.87% | -13.69% | |
79 Outperform | ¥643.72B | 13.13 | ― | 2.13% | 15.98% | 82.99% | |
76 Outperform | ¥221.44B | 14.34 | 8.53% | 2.45% | 5.14% | -10.92% | |
76 Outperform | ¥17.30B | 7.85 | ― | 2.81% | 0.23% | -8.64% | |
75 Outperform | ¥144.32B | 9.90 | ― | 1.92% | 12.72% | 28.48% | |
74 Outperform | ¥26.02B | 11.95 | ― | 7.56% | 8.01% | 13.19% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |